Cite Filings / ORKA / 0001213900-26-049372
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

Oruka Therapeutics, Inc. · Filed 2026-04-29 · Acc 0001213900-26-049372

Documents 1

  • 424B5 Prospectus , ea0288174-424b5_oruka.htm

Around this filing

  • 2026-08-28 424B5 Prospectus
  • 2026-05-01 4 Chief Operating Officer sold 5,000 shares at an average $63.88 ($319,384)
  • 2026-04-30 8-K Results of operations · Other events
  • 2026-04-29 424B5 Prospectus
  • 2026-04-27 424B5 Prospectus
  • 2026-04-27 424B5 Prospectus
  • 2026-04-27 8-K Regulation FD disclosure · Other events

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading ea0288174-424b5_oruka.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…